Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
ANTICANCER DRUG CONTAINING ALPHA, ALPHA, ALPHA-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR
No-Receipt date
2024-02167 - 11/06/2024
No-Filing date
20240401356 - 11/06/2024
No-Granting date
3092971.B2 - 25/06/2024
No-EPO application date
06712292.9 - 25/01/2006
No-EPO granting date
1849470 - 20/03/2024
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2024 - 16/07/2024
Expiration date
26/01/2026
Kind of title
Amended European Patent Validation
Legal status
VALID
Priorities
US4205926/01/2005/US
JP200516515606/06/2005/JP
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/506
A61K 31/513
A61K 31/7068
A61K 31/7072
A61P 35/00
Related Documents
Related Titles
Type
Master title
Related title
[ADD]
20170402408
[SPC]
20170800057
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1620798
TAIHO PHARMACEUTICAL CO., LTD.
1-27 KANDANISHIKI-CHO
CHIYODA-KU TOKYO 101-8444
JAPAN
Inventors
Code
Firstname
Surname
4226218
EMURA, TOMOHIRO
4226219
MITA, AKIRA
Representatives
Code
Firstname
Surname
Address
Town
Zip
2864
ELISAVET
ZOULAMOGLOU-VOZEMPERGK
ZALOKOSTA 38 KAI SYNGROY
CHALANDRI (ATTIKIS)
15233
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8810
ELISAVET
ZOULAMOGLOU-VOZEMPERGK
ZALOKOSTA 38 KAI SYNGROY
CHALANDRI (ATTIKIS)
15233
GREECE
Owners History
Title Instruments
Payments history
20 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).